Prof. Francesco Negro, Switzerland
Francesco Negro is Professor at the Departments of Specialty Medicine and of Pathology and Immunology of the University of Geneva, Switzerland. He is also Founder and Chairman of the Swiss Hepatitis C Cohort Study, Co-Editor of Liver International, and Educational Councilor of the European Association for the Study of the Liver.
More recently, Professor Negro’s work has focused on the pathogenesis of extrahepatic manifestations associated with HCV, and, particularly, on the mechanisms leading to glucose metabolism alterations, such as insulin resistance and diabetes, and on the epidemiology of HCV. He has participated in several clinical trials in acute and chronic HCV and has authored or co-authored more than 270 peer-reviewed manuscripts in the field of hepatology, and his h-index is 55. He serves in the updating committees of the clinical practice guidelines for HCV of the EASL and the World Health Organisation.
Prof. Alessio Aghemo, Italy
Prof. Alessio Aghemo (MD, PhD) received his medical degree from the University of Milan in 2001, where he also specialized in gastroenterology and later completed his post-doctoral research in gastroenterology by studying the mechanisms of Ribavirin induced anemia in patients with chronic hepatitis C.
Prof. Jason Grebely, Australia
Prof. Jason Grebely is an Associate Professor and NHRMC Career Development Fellow in the Viral Hepatitis Clinical Program at the Kirby Institute, UNSW Australia. Jason completed his BSc in Biochemistry and Molecular Biology and his PhD in Pharmacology at the University of British Columbia in Vancouver, Canada. He then completed a Post Doctoral Fellowship in Clinical Epidemiology at UNSW Australia.